View Future GrowthSofina Société Anonyme 過去の業績過去 基準チェック /16Sofina Société Anonymeの収益は年間平均-29.9%の割合で減少していますが、 Diversified Financial業界の収益は年間 増加しています。収益は年間5.8% 28.8%割合で 減少しています。 Sofina Société Anonymeの自己資本利益率は1%であり、純利益率は58.1%です。主要情報-29.89%収益成長率-29.61%EPS成長率Diversified Financial 業界の成長25.99%収益成長率-28.76%株主資本利益率1.04%ネット・マージン58.14%次回の業績アップデート02 Sep 2026最近の業績更新お知らせ • Mar 24Sofina Société Anonyme to Report Fiscal Year 2026 Results on Mar 24, 2027Sofina Société Anonyme announced that they will report fiscal year 2026 results on Mar 24, 2027お知らせ • Sep 04Sofina Société Anonyme to Report First Half, 2026 Results on Sep 03, 2026Sofina Société Anonyme announced that they will report first half, 2026 results on Sep 03, 2026お知らせ • Mar 27Sofina Société Anonyme to Report Fiscal Year 2025 Final Results on Mar 26, 2026Sofina Société Anonyme announced that they will report fiscal year 2025 final results on Mar 26, 2026お知らせ • Mar 29Sofina Société Anonyme to Report Fiscal Year 2024 Results on Mar 26, 2025Sofina Société Anonyme announced that they will report fiscal year 2024 results on Mar 26, 2025お知らせ • Jan 23Sofina Société Anonyme to Report First Half, 2024 Results on Sep 05, 2024Sofina Société Anonyme announced that they will report first half, 2024 results on Sep 05, 2024すべての更新を表示Recent updatesDeclared Dividend • May 22Dividend of €2.56 announcedShareholders will receive a dividend of €2.56. Ex-date: 27th May 2026 Payment date: 29th May 2026 Dividend yield will be 1.1%, which is lower than the industry average of 1.6%. Sustainability & Growth Dividend is not covered by earnings (109% earnings payout ratio) and the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 4.1% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. The company's earnings per share (EPS) would need to grow by 21% to bring the payout ratio under control. However, EPS has declined by 40% over the last 5 years so the company would need to reverse this trend.お知らせ • May 22Sofina Société Anonyme announces Annual dividend, payable on May 29, 2026Sofina Société Anonyme announced Annual dividend of EUR 2.5620 per share payable on May 29, 2026, ex-date on May 27, 2026 and record date on May 28, 2026.お知らせ • Apr 11Sofina Société Anonyme, Annual General Meeting, May 13, 2026Sofina Société Anonyme, Annual General Meeting, May 13, 2026, at 15:00 Romance Standard Time.New Risk • Mar 29New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 58% Last year net profit margin: 95% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 30% per year over the past 5 years. Minor Risk Profit margins are more than 30% lower than last year (58% net profit margin).お知らせ • Mar 24Sofina Société Anonyme to Report Fiscal Year 2026 Results on Mar 24, 2027Sofina Société Anonyme announced that they will report fiscal year 2026 results on Mar 24, 2027New Risk • Mar 23New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2025. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 25% per year over the past 5 years. Minor Risk Latest financial reports are more than 6 months old (reported June 2025 fiscal period end).新しいナラティブ • Feb 04Why I invest in Sofina (Dividend growth)NAV As Sofina is an investment holding company, NAV is an important factor in my evaluation. This Net Asset Value is estimated at a price share of 297 Eur, up from 294 last year.分析記事 • Jan 02Getting In Cheap On Sofina Société Anonyme (EBR:SOF) Is UnlikelyWhen close to half the companies in Belgium have price-to-earnings ratios (or "P/E's") below 15x, you may consider...お知らせ • Oct 30Terumo Corporation (TSE:4543) completed the acquisition of remaining 99.5% stake in OrganOx Limited from a group of shareholders.Terumo Corporation (TSE:4543) has entered into a definitive agreement to acquire remaining 99.5% stake in OrganOx Limited from a group of shareholders for $1.5 billion on August 23, 2025. Upon completion of the transaction, OrganOx will become a wholly owned subsidiary of Terumo. The transaction will be funded from cash on hand and borrowings. For the period ending December 31, 2024, OrganOx Limited reported total revenue of $69.14 million and EBIT of $9.01 million. As of December 31, 2024, OrganOx Limited reported total assets of $96.9 million and total common equity of $71.56 million. The transaction is subject to approval by regulatory board / committee. The transaction is expected to close in FY2025. Perella Weinberg Partners and Piper Sandler served as OrganOx’s financial advisors and Robbie McLaren, Ross McAloon, Charles Ruck, Elizabeth Richards, Betty Pang, Chad Jennings, Sean Finn, Maj Vaseghi, Kendall Burnett, Hector Armengod, Patrick English, Catherine Hein and Philipp Studt of Latham & Watkins acted as legal counsel to OrganOx in this transaction. Terumo Corporation (TSE:4543) completed the acquisition of remaining 99.5% stake in OrganOx Limited from a group of shareholders on October 29, 2025.分析記事 • Sep 07Some Shareholders Feeling Restless Over Sofina Société Anonyme's (EBR:SOF) P/E RatioSofina Société Anonyme's ( EBR:SOF ) price-to-earnings (or "P/E") ratio of 20.2x might make it look like a sell right...お知らせ • Sep 04Sofina Société Anonyme to Report First Half, 2026 Results on Sep 03, 2026Sofina Société Anonyme announced that they will report first half, 2026 results on Sep 03, 2026お知らせ • Aug 25Terumo Corporation (TSE:4543) has entered into a definitive agreement to acquire 99.5% stake in OrganOx Limited from a group of shareholders in a transaction valued at $1.5 billion.Terumo Corporation (TSE:4543) has entered into a definitive agreement to acquire 99.5% stake in OrganOx Limited from a group of shareholders in a transaction valued at $1.5 billion on August 23, 2025. Upon completion of the transaction, OrganOx will become a wholly owned subsidiary of Terumo. For the period ending December 31, 2024, OrganOx Limited reported total revenue of $69.14 million and EBIT of $9.01 million. As of December 31, 2024, OrganOx Limited reported total assets of $96.9 million and total common equity of $71.56 million. The transaction is subject to approval by regulatory board / committee. Perella Weinberg Partners and Piper Sandler served as OrganOx’s financial advisors and Latham & Watkins acted as legal counsel to OrganOx in this transaction.Upcoming Dividend • May 13Upcoming dividend of €2.45 per shareEligible shareholders must have bought the stock before 20 May 2025. Payment date: 22 May 2025. Payout ratio is a comfortable 8.6% but the company is paying out more than the cash it is generating. Trailing yield: 1.4%. Lower than top quartile of Belgian dividend payers (6.7%). Lower than average of industry peers (2.8%).お知らせ • Apr 25Proeduca Summa, S.L., Renta Genova, S.L., Asua Inversiones, S.L., Portobello Capital Gestión, SGEIC, S.A. and Sofina Société Anonyme (ENXTBR:SOF) proposed to acquire 7.09% stake in Proeduca Altus, S.A. (BME:PRO) for approximately €110 million.Proeduca Summa, S.L., Renta Genova, S.L., Asua Inversiones, S.L., Portobello Capital Gestión, SGEIC, S.A. and Sofina Société Anonyme (ENXTBR:SOF) proposed to acquire 7.09% stake in Proeduca Altus, S.A. (BME:PRO) for approximately €110 million on April 24, 2025. A cash consideration valued at €34.01 per share will be paid by Proeduca Summa, S.L., Renta Genova, S.L., Asua Inversiones, S.L., Portobello Capital Gestión, SGEIC, S.A. and Sofina Société Anonyme. As part of consideration, an undisclosed value is paid towards common equity of Proeduca Altus, S.A. The proposed price for the offer is €34.01 per share, valuing the Proeduca Altus at approximately €1.536 billion. The transaction is subject to Proeduca Altus shareholders approval. Ernst & Young Transaction Advisory Services España acted as fairness opinion provider to Proeduca Altus, S.A.お知らせ • Mar 27Sofina Société Anonyme to Report Fiscal Year 2025 Final Results on Mar 26, 2026Sofina Société Anonyme announced that they will report fiscal year 2025 final results on Mar 26, 2026New Risk • Mar 24New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 35% per year over the past 5 years. Minor Risk Latest financial reports are more than 6 months old (reported June 2024 fiscal period end).Price Target Changed • Jul 11Price target decreased by 14% to €292Down from €341, the current price target is an average from 3 analysts. New target price is 36% above last closing price of €214. Stock is up 9.3% over the past year. The company posted a net loss per share of €3.12 last year.お知らせ • Apr 04Sofina Société Anonyme, Annual General Meeting, May 08, 2025Sofina Société Anonyme, Annual General Meeting, May 08, 2025.お知らせ • Mar 29Sofina Société Anonyme to Report Fiscal Year 2024 Results on Mar 26, 2025Sofina Société Anonyme announced that they will report fiscal year 2024 results on Mar 26, 2025New Risk • Mar 24New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 22% per year over the past 5 years. Revenue is less than US$1m. Minor Risk Latest financial reports are more than 6 months old (reported June 2023 fiscal period end).お知らせ • Jan 23Sofina Société Anonyme to Report First Half, 2024 Results on Sep 05, 2024Sofina Société Anonyme announced that they will report first half, 2024 results on Sep 05, 2024お知らせ • Dec 20Proofpoint, Inc. acquire Tessian Limited.Proofpoint, Inc. entered into a definitive agreement to acquire Tessian Limited on October 30, 2023. Tessian’s solutions are expected to become part of Proofpoint’s offering upon the closing of the acquisition. The acquisition is expected to close in late 2023 to early 2024, subject to customary closing conditions, including any required regulatory approvals. Piper Sandler Ltd. acted as financial advisor to Tessian Limited. Vincent Bergin, Peter Stach, P.C., Andrew Struckmeyer, David Higgins, Corey D. Fox, P.C., Bradley C. Reed, P.C., John Patten, Peter Abbott, Matthew Sinclair-Thomson, Kirsteen Nicol, Katherine C. Nemeth, Michael Falk, P.C., Sydney Jones and Jackson Phinney of Kirkland & Ellis International LLP and Kirkland & Ellis LLP acted as legal advisor to Proofpoint. The transaction is closed on December 19, 2023.Proofpoint, Inc. completed the acquisition of Tessian Limited on December 19, 2023.Upcoming Dividend • May 05Upcoming dividend of €2.27 per share at 1.6% yieldEligible shareholders must have bought the stock before 12 May 2023. Payment date: 16 May 2023. The company is not currently making a profit but it is cash flow positive. Trailing yield: 1.6%. Lower than top quartile of Belgian dividend payers (6.4%). Lower than average of industry peers (2.6%).Price Target Changed • Nov 16Price target decreased to €367Down from €415, the current price target is an average from 2 analysts. New target price is 66% above last closing price of €221. Stock is down 45% over the past year. The company posted earnings per share of €76.99 last year.Price Target Changed • Jun 01Price target decreased to €367Down from €420, the current price target is provided by 1 analyst. New target price is 69% above last closing price of €217. Stock is down 37% over the past year. The company posted earnings per share of €76.99 last year.Valuation Update With 7 Day Price Move • May 24Investor sentiment deteriorated over the past weekAfter last week's 17% share price decline to €234, the stock trades at a trailing P/E ratio of 3x. Average trailing P/E is 9x in the Diversified Financial industry in Europe. Total returns to shareholders of 35% over the past three years.Upcoming Dividend • May 06Upcoming dividend of €2.19 per shareEligible shareholders must have bought the stock before 13 May 2022. Payment date: 17 May 2022. Payout ratio is a comfortable 4.1% but the company is not cash flow positive. Trailing yield: 1.1%. Lower than top quartile of Belgian dividend payers (5.7%). Lower than average of industry peers (2.6%).Price Target Changed • Jul 24Price target increased to €348Up from €310, the current price target is provided by 1 analyst. New target price is 12% below last closing price of €396. Stock is up 70% over the past year.Price Target Changed • Mar 22Price target increased to €310Up from €283, the current price target is provided by 1 analyst. New target price is 6.7% above last closing price of €291. Stock is up 74% over the past year.Is New 90 Day High Low • Feb 03New 90-day high: €286The company is up 22% from its price of €235 on 04 November 2020. The Belgian market is up 16% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Diversified Financial industry, which is up 17% over the same period.Is New 90 Day High Low • Dec 29New 90-day high: €275The company is up 18% from its price of €233 on 30 September 2020. The Belgian market is up 14% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Diversified Financial industry, which is up 12% over the same period.Is New 90 Day High Low • Nov 17New 90-day high: €260The company is up 7.0% from its price of €243 on 19 August 2020. The Belgian market is up 10.0% over the last 90 days, indicating the company underperformed over that time. However, it outperformed the Diversified Financial industry, which is up 5.0% over the same period.Is New 90 Day High Low • Oct 29New 90-day low: €223The company is down 4.0% from its price of €234 on 30 July 2020. The Belgian market is down 6.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Diversified Financial industry, which is down 6.0% over the same period.収支内訳Sofina Société Anonyme の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。収益と収入の歴史ENXTBR:SOF 収益、費用、利益 ( )EUR Millions日付収益収益G+A経費研究開発費31 Dec 2519411360030 Sep 2534026457030 Jun 2548641554031 Mar 2595988755031 Dec 241,4321,36056030 Sep 2496589651030 Jun 2449743346031 Mar 2422116439031 Dec 23-55-10433030 Sep 23-266-31332030 Jun 23-478-52132031 Mar 23-1,149-1,19634031 Dec 22-1,820-1,87236030 Sep 22-1,046-1,10746030 Jun 22-273-34355031 Mar 221,1911,12545031 Dec 212,6542,59336030 Sep 212,9442,89232030 Jun 213,2333,19029031 Mar 212,3272,28529031 Dec 201,4211,37929030 Sep 2094190126030 Jun 2046042224031 Mar 2084881124031 Dec 191,2351,20024030 Sep 191,1151,07423030 Jun 1999494823031 Mar 1994890523031 Dec 1890286123030 Sep 1885982417030 Jun 1881578812031 Mar 1867364312031 Dec 1753149912030 Sep 1743641413030 Jun 1736634214031 Mar 1732430514031 Dec 1628326814030 Sep 1625423613030 Jun 1622620513031 Mar 1628525613031 Dec 1534430713030 Sep 1536932712030 Jun 15394347110質の高い収益: SOFは 高品質の収益 を持っています。利益率の向上: SOFの現在の純利益率 (58.1%)は、昨年(94.9%)よりも低くなっています。フリー・キャッシュフローと収益の比較過去の収益成長分析収益動向: SOFの収益は過去 5 年間で年間29.9%減少しました。成長の加速: SOFは過去 1 年間の収益成長がマイナスであったため、5 年間の平均と比較することはできません。収益対業界: SOFは過去 1 年間で収益成長率がマイナス ( -91.7% ) となったため、 Diversified Financial業界平均 ( 10% ) と比較することが困難です。株主資本利益率高いROE: SOFの 自己資本利益率 ( 1% ) は 低い とみなされます。総資産利益率使用総資本利益率過去の好業績企業の発掘7D1Y7D1Y7D1YDiversified-financials 、過去の業績が好調な企業。View Financial Health企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/06/08 10:02終値2026/06/08 00:00収益2025/12/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Sofina Société Anonyme 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。1 アナリスト機関Marc DebrouwerDegroof Petercam
お知らせ • Mar 24Sofina Société Anonyme to Report Fiscal Year 2026 Results on Mar 24, 2027Sofina Société Anonyme announced that they will report fiscal year 2026 results on Mar 24, 2027
お知らせ • Sep 04Sofina Société Anonyme to Report First Half, 2026 Results on Sep 03, 2026Sofina Société Anonyme announced that they will report first half, 2026 results on Sep 03, 2026
お知らせ • Mar 27Sofina Société Anonyme to Report Fiscal Year 2025 Final Results on Mar 26, 2026Sofina Société Anonyme announced that they will report fiscal year 2025 final results on Mar 26, 2026
お知らせ • Mar 29Sofina Société Anonyme to Report Fiscal Year 2024 Results on Mar 26, 2025Sofina Société Anonyme announced that they will report fiscal year 2024 results on Mar 26, 2025
お知らせ • Jan 23Sofina Société Anonyme to Report First Half, 2024 Results on Sep 05, 2024Sofina Société Anonyme announced that they will report first half, 2024 results on Sep 05, 2024
Declared Dividend • May 22Dividend of €2.56 announcedShareholders will receive a dividend of €2.56. Ex-date: 27th May 2026 Payment date: 29th May 2026 Dividend yield will be 1.1%, which is lower than the industry average of 1.6%. Sustainability & Growth Dividend is not covered by earnings (109% earnings payout ratio) and the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 4.1% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. The company's earnings per share (EPS) would need to grow by 21% to bring the payout ratio under control. However, EPS has declined by 40% over the last 5 years so the company would need to reverse this trend.
お知らせ • May 22Sofina Société Anonyme announces Annual dividend, payable on May 29, 2026Sofina Société Anonyme announced Annual dividend of EUR 2.5620 per share payable on May 29, 2026, ex-date on May 27, 2026 and record date on May 28, 2026.
お知らせ • Apr 11Sofina Société Anonyme, Annual General Meeting, May 13, 2026Sofina Société Anonyme, Annual General Meeting, May 13, 2026, at 15:00 Romance Standard Time.
New Risk • Mar 29New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 58% Last year net profit margin: 95% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 30% per year over the past 5 years. Minor Risk Profit margins are more than 30% lower than last year (58% net profit margin).
お知らせ • Mar 24Sofina Société Anonyme to Report Fiscal Year 2026 Results on Mar 24, 2027Sofina Société Anonyme announced that they will report fiscal year 2026 results on Mar 24, 2027
New Risk • Mar 23New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2025. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 25% per year over the past 5 years. Minor Risk Latest financial reports are more than 6 months old (reported June 2025 fiscal period end).
新しいナラティブ • Feb 04Why I invest in Sofina (Dividend growth)NAV As Sofina is an investment holding company, NAV is an important factor in my evaluation. This Net Asset Value is estimated at a price share of 297 Eur, up from 294 last year.
分析記事 • Jan 02Getting In Cheap On Sofina Société Anonyme (EBR:SOF) Is UnlikelyWhen close to half the companies in Belgium have price-to-earnings ratios (or "P/E's") below 15x, you may consider...
お知らせ • Oct 30Terumo Corporation (TSE:4543) completed the acquisition of remaining 99.5% stake in OrganOx Limited from a group of shareholders.Terumo Corporation (TSE:4543) has entered into a definitive agreement to acquire remaining 99.5% stake in OrganOx Limited from a group of shareholders for $1.5 billion on August 23, 2025. Upon completion of the transaction, OrganOx will become a wholly owned subsidiary of Terumo. The transaction will be funded from cash on hand and borrowings. For the period ending December 31, 2024, OrganOx Limited reported total revenue of $69.14 million and EBIT of $9.01 million. As of December 31, 2024, OrganOx Limited reported total assets of $96.9 million and total common equity of $71.56 million. The transaction is subject to approval by regulatory board / committee. The transaction is expected to close in FY2025. Perella Weinberg Partners and Piper Sandler served as OrganOx’s financial advisors and Robbie McLaren, Ross McAloon, Charles Ruck, Elizabeth Richards, Betty Pang, Chad Jennings, Sean Finn, Maj Vaseghi, Kendall Burnett, Hector Armengod, Patrick English, Catherine Hein and Philipp Studt of Latham & Watkins acted as legal counsel to OrganOx in this transaction. Terumo Corporation (TSE:4543) completed the acquisition of remaining 99.5% stake in OrganOx Limited from a group of shareholders on October 29, 2025.
分析記事 • Sep 07Some Shareholders Feeling Restless Over Sofina Société Anonyme's (EBR:SOF) P/E RatioSofina Société Anonyme's ( EBR:SOF ) price-to-earnings (or "P/E") ratio of 20.2x might make it look like a sell right...
お知らせ • Sep 04Sofina Société Anonyme to Report First Half, 2026 Results on Sep 03, 2026Sofina Société Anonyme announced that they will report first half, 2026 results on Sep 03, 2026
お知らせ • Aug 25Terumo Corporation (TSE:4543) has entered into a definitive agreement to acquire 99.5% stake in OrganOx Limited from a group of shareholders in a transaction valued at $1.5 billion.Terumo Corporation (TSE:4543) has entered into a definitive agreement to acquire 99.5% stake in OrganOx Limited from a group of shareholders in a transaction valued at $1.5 billion on August 23, 2025. Upon completion of the transaction, OrganOx will become a wholly owned subsidiary of Terumo. For the period ending December 31, 2024, OrganOx Limited reported total revenue of $69.14 million and EBIT of $9.01 million. As of December 31, 2024, OrganOx Limited reported total assets of $96.9 million and total common equity of $71.56 million. The transaction is subject to approval by regulatory board / committee. Perella Weinberg Partners and Piper Sandler served as OrganOx’s financial advisors and Latham & Watkins acted as legal counsel to OrganOx in this transaction.
Upcoming Dividend • May 13Upcoming dividend of €2.45 per shareEligible shareholders must have bought the stock before 20 May 2025. Payment date: 22 May 2025. Payout ratio is a comfortable 8.6% but the company is paying out more than the cash it is generating. Trailing yield: 1.4%. Lower than top quartile of Belgian dividend payers (6.7%). Lower than average of industry peers (2.8%).
お知らせ • Apr 25Proeduca Summa, S.L., Renta Genova, S.L., Asua Inversiones, S.L., Portobello Capital Gestión, SGEIC, S.A. and Sofina Société Anonyme (ENXTBR:SOF) proposed to acquire 7.09% stake in Proeduca Altus, S.A. (BME:PRO) for approximately €110 million.Proeduca Summa, S.L., Renta Genova, S.L., Asua Inversiones, S.L., Portobello Capital Gestión, SGEIC, S.A. and Sofina Société Anonyme (ENXTBR:SOF) proposed to acquire 7.09% stake in Proeduca Altus, S.A. (BME:PRO) for approximately €110 million on April 24, 2025. A cash consideration valued at €34.01 per share will be paid by Proeduca Summa, S.L., Renta Genova, S.L., Asua Inversiones, S.L., Portobello Capital Gestión, SGEIC, S.A. and Sofina Société Anonyme. As part of consideration, an undisclosed value is paid towards common equity of Proeduca Altus, S.A. The proposed price for the offer is €34.01 per share, valuing the Proeduca Altus at approximately €1.536 billion. The transaction is subject to Proeduca Altus shareholders approval. Ernst & Young Transaction Advisory Services España acted as fairness opinion provider to Proeduca Altus, S.A.
お知らせ • Mar 27Sofina Société Anonyme to Report Fiscal Year 2025 Final Results on Mar 26, 2026Sofina Société Anonyme announced that they will report fiscal year 2025 final results on Mar 26, 2026
New Risk • Mar 24New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 35% per year over the past 5 years. Minor Risk Latest financial reports are more than 6 months old (reported June 2024 fiscal period end).
Price Target Changed • Jul 11Price target decreased by 14% to €292Down from €341, the current price target is an average from 3 analysts. New target price is 36% above last closing price of €214. Stock is up 9.3% over the past year. The company posted a net loss per share of €3.12 last year.
お知らせ • Apr 04Sofina Société Anonyme, Annual General Meeting, May 08, 2025Sofina Société Anonyme, Annual General Meeting, May 08, 2025.
お知らせ • Mar 29Sofina Société Anonyme to Report Fiscal Year 2024 Results on Mar 26, 2025Sofina Société Anonyme announced that they will report fiscal year 2024 results on Mar 26, 2025
New Risk • Mar 24New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 22% per year over the past 5 years. Revenue is less than US$1m. Minor Risk Latest financial reports are more than 6 months old (reported June 2023 fiscal period end).
お知らせ • Jan 23Sofina Société Anonyme to Report First Half, 2024 Results on Sep 05, 2024Sofina Société Anonyme announced that they will report first half, 2024 results on Sep 05, 2024
お知らせ • Dec 20Proofpoint, Inc. acquire Tessian Limited.Proofpoint, Inc. entered into a definitive agreement to acquire Tessian Limited on October 30, 2023. Tessian’s solutions are expected to become part of Proofpoint’s offering upon the closing of the acquisition. The acquisition is expected to close in late 2023 to early 2024, subject to customary closing conditions, including any required regulatory approvals. Piper Sandler Ltd. acted as financial advisor to Tessian Limited. Vincent Bergin, Peter Stach, P.C., Andrew Struckmeyer, David Higgins, Corey D. Fox, P.C., Bradley C. Reed, P.C., John Patten, Peter Abbott, Matthew Sinclair-Thomson, Kirsteen Nicol, Katherine C. Nemeth, Michael Falk, P.C., Sydney Jones and Jackson Phinney of Kirkland & Ellis International LLP and Kirkland & Ellis LLP acted as legal advisor to Proofpoint. The transaction is closed on December 19, 2023.Proofpoint, Inc. completed the acquisition of Tessian Limited on December 19, 2023.
Upcoming Dividend • May 05Upcoming dividend of €2.27 per share at 1.6% yieldEligible shareholders must have bought the stock before 12 May 2023. Payment date: 16 May 2023. The company is not currently making a profit but it is cash flow positive. Trailing yield: 1.6%. Lower than top quartile of Belgian dividend payers (6.4%). Lower than average of industry peers (2.6%).
Price Target Changed • Nov 16Price target decreased to €367Down from €415, the current price target is an average from 2 analysts. New target price is 66% above last closing price of €221. Stock is down 45% over the past year. The company posted earnings per share of €76.99 last year.
Price Target Changed • Jun 01Price target decreased to €367Down from €420, the current price target is provided by 1 analyst. New target price is 69% above last closing price of €217. Stock is down 37% over the past year. The company posted earnings per share of €76.99 last year.
Valuation Update With 7 Day Price Move • May 24Investor sentiment deteriorated over the past weekAfter last week's 17% share price decline to €234, the stock trades at a trailing P/E ratio of 3x. Average trailing P/E is 9x in the Diversified Financial industry in Europe. Total returns to shareholders of 35% over the past three years.
Upcoming Dividend • May 06Upcoming dividend of €2.19 per shareEligible shareholders must have bought the stock before 13 May 2022. Payment date: 17 May 2022. Payout ratio is a comfortable 4.1% but the company is not cash flow positive. Trailing yield: 1.1%. Lower than top quartile of Belgian dividend payers (5.7%). Lower than average of industry peers (2.6%).
Price Target Changed • Jul 24Price target increased to €348Up from €310, the current price target is provided by 1 analyst. New target price is 12% below last closing price of €396. Stock is up 70% over the past year.
Price Target Changed • Mar 22Price target increased to €310Up from €283, the current price target is provided by 1 analyst. New target price is 6.7% above last closing price of €291. Stock is up 74% over the past year.
Is New 90 Day High Low • Feb 03New 90-day high: €286The company is up 22% from its price of €235 on 04 November 2020. The Belgian market is up 16% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Diversified Financial industry, which is up 17% over the same period.
Is New 90 Day High Low • Dec 29New 90-day high: €275The company is up 18% from its price of €233 on 30 September 2020. The Belgian market is up 14% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Diversified Financial industry, which is up 12% over the same period.
Is New 90 Day High Low • Nov 17New 90-day high: €260The company is up 7.0% from its price of €243 on 19 August 2020. The Belgian market is up 10.0% over the last 90 days, indicating the company underperformed over that time. However, it outperformed the Diversified Financial industry, which is up 5.0% over the same period.
Is New 90 Day High Low • Oct 29New 90-day low: €223The company is down 4.0% from its price of €234 on 30 July 2020. The Belgian market is down 6.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Diversified Financial industry, which is down 6.0% over the same period.
